{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:06:55Z","timestamp":1792069615387,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several lipid parameters are closely associated with residual cardiovascular risk. We aimed to confirm that in a range of low-density lipoprotein cholesterol (LDL-c) levels (from &lt;70\u2009mg\/dl to \u2265160\u2009mg\/dl), other lipid parameters, such as triglyceride (TG) level, non-high-density lipoprotein cholesterol (non-HDL-c) level, and the total cholesterol (TC)\/HDL-c ratio, are still related to arterial stiffness, which is a recognized marker of atherosclerosis. In this cross-sectional study, we measured brachial-ankle pulse wave velocity (baPWV), as well as clinical and biochemical indices in 16,733 Chinese adult volunteers who underwent health check-ups from January 2014 to January 2015. Arterial stiffness was defined as the upper quartile of baPWV. We applied multivariable logistic regression models to examine the associations between lipid parameters and arterial stiffness. Both men and women with high baPWV were more likely to have an atherogenic lipid phenotype. Among participants with LDL-c &lt;70\u2009mg\/dl, participants with non-HDL-c \u2265100\u2009mg\/dl had a multivariable adjusted OR for arterial stiffness of 1.66 (1.11\u20132.50) compared to those with non-HDL-c &lt;100\u2009mg\/dl; participants with TG \u2265150\u2009mg\/dl had an OR of 2.44 (1.61\u20133.71) compared to those with TG &lt;150\u2009mg\/dl; and participants with a TC\/HDL-c ratio \u22654 had an OR of 1.74 (1.15\u20132.65) compared to those with a TC\/HDL-c ratio &lt;4. Similar results were observed at other LDL-c levels. We found that non-HDL-c, TG, and the TC\/HDL-c ratio were consistently associated with arterial stiffness in a range of LDL-c levels, even when LDL-c was below 70\u2009mg\/dl. These lipid measures are related to residual cardiovascular risk, possibly due to their detrimental effects on vascular structure.<\/jats:p>","DOI":"10.1038\/s41440-019-0251-5","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T13:11:38Z","timestamp":1553692298000},"page":"1223-1230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol\/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population"],"prefix":"10.1038","volume":"42","author":[{"given":"Jia","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"251_CR1","first-page":"e38","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart Disease and Stroke Statistics-2016 Update: a report from the American Heart Association. Circulation. 2016;133:e38\u2013360.","journal-title":"Circulation"},{"key":"251_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jama.294.3.326","volume":"294","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. J Am Med Assoc. 2005;294:326\u201333.","journal-title":"J Am Med Assoc"},{"key":"251_CR3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Cholesterol Treatment Trialists\u2019 (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90\u2008056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267\u201378.","journal-title":"Lancet"},{"key":"251_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","volume":"44","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr., Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44:720\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"251_CR5","unstructured":"Authors\/Task Force Members :Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention and Rehabilitation (EACPR). Atherosclerosis. 2016;253:281\u2013344."},{"key":"251_CR6","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1161\/CIRCULATIONAHA.107.713438","volume":"117","author":"JJ Kastelein","year":"2008","unstructured":"Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, et al. TNT Study Group; IDEAL Study Group. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008;117:3002\u20139.","journal-title":"Circulation"},{"key":"251_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","volume":"55","author":"BJ Arsenault","year":"2009","unstructured":"Arsenault BJ, Rana JS, Stroes ES, Despres JP, Shah PK, Kastelein JJ, et al. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol\/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol. 2009;55:35\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"251_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jacc.2011.12.035","volume":"59","author":"S Mora","year":"2012","unstructured":"Mora S, Glynn RJ, Boekholdt SM, Nordestgaard BG, Kastelein JJ, Ridker PM. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). J Am Coll Cardiol. 2012;59:1521\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"251_CR9","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.111.088591","volume":"125","author":"S Mora","year":"2012","unstructured":"Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, et al. Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation. 2012;125:1979\u201387.","journal-title":"Circulation"},{"key":"251_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jacc.2011.01.055","volume":"58","author":"R Blankstein","year":"2011","unstructured":"Blankstein R, Budoff MJ, Shaw LJ, Goff DC Jr., Polak JF, Lima J, et al. Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58:364\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"251_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/01.ATV.0000160548.78317.29","volume":"25","author":"SJ Zieman","year":"2005","unstructured":"Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"251_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000443740","volume":"3","author":"M Munakata","year":"2016","unstructured":"Munakata M. Brachial-ankle pulse wave velocity: background, method, and clinical evidence. Pulse. 2016;3:195\u2013204.","journal-title":"Pulse"},{"key":"251_CR13","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1097\/HJH.0b013e32832e94e7","volume":"27","author":"H Tanaka","year":"2009","unstructured":"Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27:2022\u20137.","journal-title":"J Hypertens"},{"key":"251_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.112.194779","volume":"60","author":"C Vlachopoulos","year":"2012","unstructured":"Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, Ioakeimidis N, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension . 2012;60:556\u201362.","journal-title":"Hypertension"},{"key":"251_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.117.09097","volume":"69","author":"T Ohkuma","year":"2017","unstructured":"Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, et al. Collaborative Group for J-BAVEL (Japan brachial-ankle pulse wave velocity individual participant data meta-analysis of prospective studies)*. Brachial-ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertension. 2017;69:1045\u201352.","journal-title":"Hypertension"},{"key":"251_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2796.2010.02277.x","volume":"268","author":"S Holewijn","year":"2010","unstructured":"Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J. Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk. J Intern Med. 2010;268:567\u201377.","journal-title":"J Intern Med"},{"key":"251_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-017-0451-4","volume":"16","author":"H Ma","year":"2017","unstructured":"Ma H, Lin H, Hu Y, Li X, He W, Jin X, et al. Relationship between non-high-density lipoprotein cholesterol and carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults. Lipids Health Dis. 2017;16:55.","journal-title":"Lipids Health Dis"},{"key":"251_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/jch.13038","volume":"19","author":"J Wen","year":"2017","unstructured":"Wen J, Zhong Y, Kuang C, Liao J, Chen Z, Yang Q. Lipoprotein ratios are better than conventional lipid parameters in predicting arterial stiffness in young men. J Clin Hypertens. 2017;19:771\u20136.","journal-title":"J Clin Hypertens"},{"key":"251_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-016-0465-7","volume":"15","author":"L Gomez-Sanchez","year":"2016","unstructured":"Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, Fernando R, Marti R, et al. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol. 2016;15:148.","journal-title":"Cardiovasc Diabetol"},{"key":"251_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2015.03.031","volume":"240","author":"L Chen","year":"2015","unstructured":"Chen L, Zhu W, Mai L, Fang L, Ying K. The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in south China. Atherosclerosis. 2015;240:345\u201350.","journal-title":"Atherosclerosis"},{"key":"251_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/01.HYP.0000198539.34501.1a","volume":"47","author":"H Tomiyama","year":"2006","unstructured":"Tomiyama H, Hashimoto H, Hirayama Y, Yambe M, Yamada J, Koji Y, et al. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension. 2006;47:180\u20138.","journal-title":"Hypertension"},{"key":"251_CR22","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1159\/000485861","volume":"42","author":"J Wen","year":"2017","unstructured":"Wen J, Chen Y, Huang Y, Lu Y, Liu X, Zhou H, et al. Association of the TG\/HDL-C and Non-HDL-C\/HDL-C Ratios with Chronic Kidney Disease in an Adult Chinese Population. Kidney Blood Press Res. 2017;42:1141\u201354.","journal-title":"Kidney Blood Press Res"},{"key":"251_CR23","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV C Chobanian","year":"2003","unstructured":"C Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention detection evaluation and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc. 2003;289:2560\u201371.","journal-title":"J Am Med Assoc"},{"key":"251_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1291\/hypres.26.615","volume":"26","author":"A Yamashina","year":"2003","unstructured":"Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003;26:615\u201322.","journal-title":"Hypertens Res"},{"key":"251_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.numecd.2012.08.001","volume":"23","author":"WW Zhao","year":"2013","unstructured":"Zhao WW, Yang YH, Lu B, Feng XC, He M, Yang ZH, et al. Serum high-density lipoprotein cholesterol and progression to arterial stiffness in middle-aged and elderly Chinese. Nutr Metab Cardiovasc Dis. 2013;23:973\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"251_CR26","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.jacc.2009.12.042","volume":"55","author":"H Tomiyama","year":"2010","unstructured":"Tomiyama H, Hashimoto H, Tanaka H, Matsumoto C, Odaira M, Yamada J, et al. Continuous smoking and progression of arterial stiffening: a prospective study. J Am Coll Cardiol. 2010;55:1979\u201387.","journal-title":"J Am Coll Cardiol"},{"key":"251_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.hdy.6800717","volume":"95","author":"J Li","year":"2005","unstructured":"Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity. 2005;95:221\u20137.","journal-title":"Heredity"},{"key":"251_CR28","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","volume":"34","author":"AB Jorgensen","year":"2013","unstructured":"Jorgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybjaerg-Hansen A. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J. 2013;34:1826\u201333.","journal-title":"Eur Heart J"},{"key":"251_CR29","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1001\/archinte.161.22.2685","volume":"161","author":"I Lemieux","year":"2001","unstructured":"Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, et al. Total cholesterol\/HDL cholesterol ratio vs LDL cholesterol\/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med. 2001;161:2685\u201392.","journal-title":"Arch Intern Med"},{"key":"251_CR30","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","volume":"285","author":"PM Ridker","year":"2001","unstructured":"Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481\u20135.","journal-title":"JAMA"},{"key":"251_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.107.719369","volume":"117","author":"AD Pradhan","year":"2008","unstructured":"Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation. 2008;117:823\u201331.","journal-title":"Circulation"},{"key":"251_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1476-511X-13-37","volume":"13","author":"W Zhao","year":"2014","unstructured":"Zhao W, Gong W, Wu N, Li Y, Ye K, Lu B, et al. Association of lipid profiles and the ratios with arterial stiffness in middle-aged and elderly Chinese. Lipids Health Dis. 2014;13:37.","journal-title":"Lipids Health Dis"},{"key":"251_CR33","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.108.127043","volume":"53","author":"TE Brinkley","year":"2009","unstructured":"Brinkley TE, Nicklas BJ, Kanaya AM, Satterfield S, Lakatta EG, Simonsick EM, et al. Plasma oxidized low-density lipoprotein levels and arterial stiffness in older adults: the health, aging, and body composition study. Hypertension. 2009;53:846\u201352.","journal-title":"Hypertension"},{"key":"251_CR34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1253\/circj.72.722","volume":"72","author":"M Hongo","year":"2008","unstructured":"Hongo M, Tsutsui H, Mawatari E, Hidaka H, Kumazaki S, Yazaki Y, et al. Fluvastatin improves arterial stiffness in patients with coronary artery disease and hyperlipidemia. Circ J. 2008;72:722\u20138.","journal-title":"Circ J"},{"key":"251_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/sj.jhh.1001786","volume":"19","author":"A Ichihara","year":"2005","unstructured":"Ichihara A, Hayashi M, Koura Y, Tada Y, Kaneshiro Y, Saruta T. Long-term effects of statins on arterial pressure and stiffness of hypertensives. J Hum Hypertens. 2005;19:103\u20139.","journal-title":"J Hum Hypertens"},{"key":"251_CR36","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/gme.0b013e318259c04e","volume":"19","author":"M Igase","year":"2012","unstructured":"Igase M, Kohara K, Tabara Y, Nagai T, Ochi N, Kido T, et al. Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia. Menopause. 2012;19:1294\u20139.","journal-title":"Menopause"},{"key":"251_CR37","doi-asserted-by":"publisher","first-page":"e41369","DOI":"10.1371\/journal.pone.0041369","volume":"7","author":"K Toyama","year":"2012","unstructured":"Toyama K, Sugiyama S, Oka H, Iwasaki Y, Sumida H, Tanaka T, et al. Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease. PloS ONE. 2012;7:e41369.","journal-title":"PloS ONE"},{"key":"251_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ijcard.2016.11.073","volume":"227","author":"S Upala","year":"2017","unstructured":"Upala S, Wirunsawanya K, Jaruvongvanich V, Sanguankeo A. Effects of statin therapy on arterial stiffness: a systematic review and meta-analysis of randomized controlled trial. Int J Cardiol. 2017;227:338\u201341.","journal-title":"Int J Cardiol"},{"key":"251_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/ajim.4700200505","volume":"20","author":"IJ Selikoff","year":"1991","unstructured":"Selikoff IJ, Seidman H. Evaluation of selection bias in a cross-sectional survey. Am J Ind Med. 1991;20:615\u201327.","journal-title":"Am J Ind Med"},{"key":"251_CR40","unstructured":"Sui H, Chen W, Wang W. Interpretation of report on cardiovascular diseases in China (2015). Chin J Cardiovasc Med. 2016;21:259\u201361."},{"key":"251_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2017.12.069","volume":"260","author":"M Zhang","year":"2018","unstructured":"Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196\u2013203.","journal-title":"Int J Cardiol"},{"key":"251_CR42","first-page":"687","volume":"46","author":"JH Li","year":"2012","unstructured":"Li JH, Wang LM, Mi SQ, Zhang M, Li YC, Jiang Y, et al. Awareness rate, treatment rate and control rate of dyslipidemia in Chinese adults, 2010. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46:687\u201391.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0251-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:20:34Z","timestamp":1684603234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0251-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0251-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"6 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}